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ABSTRACT

The microbiome is a dynamic community that can positively and negatively
influence host health. Lactobacillus reuteri is a probiotic that has received much
attention for its ability to inhibit pathogens such as Salmonella Typhimurium,
Escherichia coli, and Clostridium difficile. It does so by its unique ability to metabolize
glycerol into the antimicrobial compound 3-HPA, which is commonly referred to as
reuterin. The ability to secrete reuterin is dependent not only on glycerol availability but
also the concentration of glucose. In fact, there appears to be a “goldilocks” ratio
between glucose and glycerol as either too much or too little glucose significantly
diminishes reuterin production. Since L. reuteri primarily resides in distal regions of the
intestine and colon where most of the glucose has already been absorbed, it seems
unlikely that reuterin production would be promoted at the physiological level via this
mechanism. Prebiotics are carbohydrates that are indigestible by the host and remain
for enzymatic digestion by intestinal probiotics. Inulin and galactooligosaccharides (GOS)
are two widely studied prebiotics that are known for their ability to promote the growth
of a wide range of Lactobacilli, and have been shown to promote L. reuteri growth to
varying degrees. Here, we asked if prebiotics such as inulin and GOS promote the
production of reuterin in the absence of glucose. L. reuteri were cultured in TSB with or
without glycerol in the presence of either glucose, inulin, or GOS, and assessed for their
ability to produce reuterin. While inulin did not enhance the production of reuterin, GOS
induced reuterin production, although 45% less than that of glucose. Moreover, unlike
the dose-dependence observed with glucose, incubation with GOS induced similar
v

reuterin production regardless of concentration. This suggests that an enzymatic
equilibrium may exist where glucose/galactose is cleaved from GOS only as needed by L.
reuteri. Finally, to confirm the biopotency of reuterin production, we cultured S.
Typhimurium with supernatants from L. reuteri that were grown with various
carbohydrates. Supernatant dilutions as low as 1:15 were able to significantly retard
growth of S. Typhimurium with ratios of 1:1 completely inhibiting growth. Together,
these results suggest that prebiotics such as GOS may be able to elicit physiologically
relevant production of reuterin, which may shape the flora of the microbiome and
reduce incidence and severity of pathological infections. Further, as GOS are particularly
abundant in breast milk, it suggests a possible link for early immunoprotection from
intestinal pathogens while the infant is still immunologically naïve.

Keywords: Lactobacillus reuteri, Salmonella Typhimurium, inulin, Galactooligosaccharides
(GOS), reuterin, metabolism, prebiotics, probiotics
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INTRODUCTION
Microbiome: Influence on health
The interaction and effects between human health and the microbiota have
been widely studied (D’Argenio & Salvatore, 2015; Gibson & Roberfroid, 1995).
Improper balances in the composition of the microbiome can lead to deleterious effects
on the host. For example, obesity has been correlated with elevated levels of
pathogenic bacteria in the gut (Fei & Zhao, 2013). One study in particular looked at the
ratio of one specific probiotic, Bifidobacteria, and one specific pathogen, Escherichia
coli. They found that a group of obese school aged children had a significantly lower
ratio of probiotics to pathogens (Gao et al., 2015). Other negative outcomes associated
with unhealthy gut bacterial composition are inflammatory bowel disease (D’Argenio &
Salvatore, 2015) and chronic heart failure (Pasini et al., 2016). In contrast to poor
gastrointestinal conditions, symbiotic bacteria have been seen to ameliorate certain
conditions such as constipation (Bekkali, Bongers, Van den Berg, Liem, & Benninga,
2007; Coccorullo et al., 2010; Ojetti et al., 2014), obesity (Chen et al., 2014; National
Human Genome Research Institute, n.d.), and can inhibit pathogens in vitro (De Weirdt
et al., 2012) and in vivo (Uraipan & Hongpattarakere, 2015). These beneficial bacteria
are referred to as probiotics which can be defined as living organisms that convey
beneficial health to the host or support a proper equilibrium of autochthonous microbes
within the gastrointestinal tract (Uraipan & Hongpattarakere, 2015). Two genera most
commonly studied for their favorable effects upon human health are Bifidobacteria and
Lactobacilli. Probiotics generally exert their positive shift in a balanced microbiome in
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one of two ways. The first is through occupying a physical niche within the gut by which
they are able to limit any pathogen adherence to intestinal walls. The second
mechanism involved in probiotic activity is in the secretion of an antimicrobial substance
that inhibits pathogen (De Weirdt et al., 2012; Kšonžeková et al., 2016). The secreted
antimicrobial typically either kills pathogenic organisms, or it prevents adherence to
intestinal walls thereby preventing niche establishment; both mechanisms effectively
shift the gastrointestinal equilibrium. Probiotics produce microbial inhibition by
excreting exopolysaccharides, which are polysaccharides on the cell surface of gram
positive bacteria that then can be released into the adjacent vicinity (Chapot-Chartier &
Kulakauskas, 2014), or other compounds with antimicrobial properties including
bacteriocin peptides (De Weirdt et al., 2012; Kšonžeková et al., 2016; Schaefer et al.,
2010; Silva Sabo, Converti, Todorov, Domínguez, & Souza Oliveira, 2015). Because of
probiotics’ anti-pathogenic properties and correlation with health, much research has
focused on elucidating how they may be promoted.
In the pursuit of enhancing the endogenous probiotic populations of the gut, a
new category of compounds was outlined. Gibson and Roberfroid first coined the term
prebiotics to describe these compounds, and characterized them as nondigestible food
stuffs that selectively promote the growth or activity of bacteria that beneficially impact
the health of the host (Gibson & Roberfroid, 1995). Further delineation can be made
between fibers and prebiotics by clarifying that fibers cannot be fermented in the gut
while prebiotics are fermentable compounds (Stewart, Savarino, & Slavin, 2009). There
are a number of prebiotics which have been studied including different types of fructans
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and oligosaccharides. These prebiotics selectively promote the growth of probiotics
(Chung et al., 2016), mainly the genera Bifidobacteria and Lactobacillus (Kneifel, 2000;
Kolida, Tuohy, & Gibson, 2002).
Changes in the microbiome have also been observed in human subjects due to
prebiotics. For example, Costabile et al. administered different prebiotics to humans to
see how they would impact the microbiota. While the overall number of bacteria
remained the same, specific probiotics, such as Bifidobacteria and Lactobacillus,
increased depending on the particular prebiotic used. At the same time, bacteria
associated with an unhealthy gut, such as Clostridia and Bacteroides, decreased in
number (Costabile et al., 2010). Not only do prebiotic effect bacterial distribution, but
Tarr et al. have also observed a significant impact on health. Mice were subjected to a
variety of conditions involving stress and prebiotics, and not only did the addition of
prebiotics help modulate the gut composition to keep it within a range of normal, but it
also prevented the mice from becoming anxious when placed in stressor situations.
(Tarr et al., 2015).

Lactobacillus reuteri and the antimicrobial production of reuterin
Lactobacillus reuteri (L. reuteri) is a probiotic with promising potential. It has
already been demonstrated to have health benefits in human studies, and studies like
the ones conducted by Ojetti et al. and Coccorullo et al. have shown the potential
advantageous outcomes associated with the L. reuteri (Coccorullo et al., 2010; Ojetti et
al., 2014). In a double-blind, randomized, placebo controlled study by Coccorullo et al.,
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supplementation of L. reuteri was investigated for its ability to alleviate the functional
chronic constipation that some infants experience. Not only did they see a significant
increase in bowel movements, but there was also no observed adverse effect resulting
from the added probiotic (Coccorullo et al., 2010). Another essential benefit of L.
reuteri’s probiotic capacity is in its inhibition of pathogenic activity. One mechanism of
inhibition is by limiting the ability of pathogens to adhere to gut epithelial cells. One
group of researchers demonstrated that L. reuteri produced an exopolysaccharide that
limited E. coli’s ability to adhere to porcine epithelial cells in vitro (Kšonžeková et al.,
2016). This is in addition to the general characteristic of probiotics ability to occupy
space that could otherwise be utilized by pathogens (Uraipan & Hongpattarakere, 2015).
Another intriguing aspect of L. reuteri’s probiotic ability is its unique metabolism of
glycerol into reuterin. De Weirdt et al. observed that the supernatant from L. reuteri
produced antimicrobial effects against Salmonella Typhimurium. In this study, they
subjected S. Typhimurium to a variety of supernatant concentrations from L. reuteri
cultures. A 1:10 concentration of supernatant from L. reuteri grown in the presence of
glycerol not only limited the adhesion of S. Typhimuirum to other cells, but it also
inhibited the actual growth of S. Typhimurium in vitro. Moreover, it was determined
that reuterin was the active antimicrobial compound that was secreted by L. reuteri (De
Weirdt et al., 2012).
Reuterin (Figure 1) is also known as 3-hydroxyproponal or 3hydroxypropionaldehyde (Schaefer et al., 2010), and is produced by a glycerol
dehydratase that is B12 dependent (Talarico & Dobrogosz, 1990). It also is clear that

4

reuterin is metabolized from glycerol and not due to an overall increased metabolism.
The precise mechanism of reuterin’s inhibition is not fully understood though it has
been seen to have a wide range of antimicrobial inhibition (Talarico & Dobrogosz, 1989),
including the pathogenic Clostridium difficile which is responsible for many extended
hospitalizations (Schaefer et al., 2010). There are currently two hypotheses to explain its
broad range of inhibition. The first is that reuterin inhibits the activity of ribonucleotide
reductase (Cleusix, Lacroix, Vollenweider, Duboux, & Le Blay, 2007; Talarico, Casas,
Chung, & Dobrogosz, 1988), the enzyme that synthesizes ribonucleotides in bacteria
(Torrents, 2014). The other proposed, and more widely accepted, hypothesis is that
reuterin introduces oxidative stress to the cells. Schaefer et al. investigated the
mechanism by which reuterin may exert its potential oxidative stress. They showed that
E. coli which had mutations for a specific gene that is involved with oxidative stress were
more susceptible to reuterin’s effect. Moreover, they also showed that excess cysteine
in the media could mitigate the antimicrobial effects of reuterin suggesting that retuerin
is interacting with thiol groups (Schaefer et al., 2010).
Inulin and Galactooligosaccharides
Inulin (Figure 1) is a known prebiotic which can promote the growth of
probiotics. Found in foods such as chicory root, Jerusalem artichoke, banana, onion, and
garlic, inulin is a polymer of carbohydrate that varies in its degrees of polymerization
(Costabile et al., 2010). It is mainly composed of fructose monomers linked by a 1-2 βglycosidic bonds of repeating length. This β-glycosidic linkage is what makes it
indigestible by human gastrointestinal enzymes. An α-glucose moiety sometimes starts
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the polymer (Roberfroid, 2005). Chung et al. meticulously verified the prebiotic activity
of inulin for various probiotics in vitro (Chung et al., 2016). These prebiotic effects have
been observed in vivo as well. One such study was conducted with humans where half
of the subjects were given inulin, and half were given a placebo of maltodextrin. Fecal
samples taken before and after revealed that the number of Lactobacilli and
Bifidobacteria increased in the experimental group. This suggests that prebiotics, and
specifically inulin, can be used to actively modulate the composition of the microbiome
(Costabile et al., 2010). Not only can inulin be given directly, but it also can be
incorporated into baked goods while still retaining its prebiotic activity thus expanding
its realistic use (Kleessen B et al., 2007). L. reuteri is known to respond to various
prebiotics of which inulin is one (Kassim, Baijnath, & Odhav, 2014).
Galactooligosaccharides (Figure 1) (GOS) are naturally occurring carbohydrates in
breast milk that are synthesized via a β-galactosidase enzyme (Macfarlane, Steed, &
Macfarlane, 2008). GOS have β-glyosidic linkages between galactose moieties of
repeating length, and most often terminate with a single glucose monomer (Austin,
Bénet, Michaud, Cuany, & Rohfritsch, 2014). GOS can often vary in degrees of
polymerization from 2 to 10 (Macfarlane et al., 2008), and are known to be metabolized
by at least two different strains of L. reuteri (Kneifel, 2000).
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Inulin

GOS

REUTERIN

Figure 1: Structures of Inulin, GOS, and Reuterin. Each of the three compounds of interest
for this research is depicted in this image. The -glycosidic bonds between the monomers in
inulin and GOS can be seen. As well, the varying degree of polymerization for both
carbohydrates is illustrated with the brackets. Reuterin is easily observed as a modified version
of glycerol by its molecular structure. (Fisch, 2006; Klaas, n.d.; Pubchem, n.d.)

Bacterial metabolism
Although prebiotics such as inulin and GOS are known to enhance the growth of
some strains of L. reuteri, it is uncertain how, or if, the metabolism of these prebiotics
impacts the overall metabolic state of the organism. Some evidence demonstrates that
prebiotics have increased the amount of antimicrobial substances produced by
probiotics. If this is true, the ingestion of prebiotics could become a medicinally
important part of a person’s diet. Our research set out to determine if metabolism of
prebiotics by L. reuteri significantly increase reuterin production. Specifically, we
7

hypothesized that the addition of prebiotics such as inulin or GOS to L. reuteri would
increase reuterin secretion and inhibit S. Typhimurium growth.
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METHODS
Bacteria, compounds, and storage
Lactobacillus reuteri PTA 6475 were obtained from the American Type Culture
Collection (Manassas, VA) and were maintained by anaerobic culture on Tryptic Soy
Agar plates. Salmonella Typhimurium was obtained from Presque Isle Cultures (Erie,
PA), and incubated aerobically on TSA plates. Plated cultures were stored at 4 o C for use
throughout experiments. Further, 10% and 20% glycerol stocks were created for longterm storage of cultures. Inulin from chicory root was obtained from Chem-Impex
International, while GOS was acquired from Bimuno. Tryptic Soy Broth (TSB) was
supplemented with 0.1% Tween 80 in all conditions as a surfactant to aid the growth of
L. reuteri [2].
Reuterin production by supplementation of inulin
L. reuteri was inoculated in TSB and twelve hours later, tubes were measured by
spectrophotometry (OD 596). Next, 180 μL of working solution (OD596 close to 0.1) was
inoculated in triplicate into Falcon tubes containing 9 mL of either TSB, TSB with 5.0%
inulin (w/v), TSB with 20 mM glycerol, or TSB with 20 mM glycerol and 5.0% inulin.
Cultures were incubated with shaking for 16 hours at 37°C. Following this incubation, L.
reuteri, were pelleted by centrifugation at 1500 rcf for 10 minutes. The supernatant was
removed, and the pellets were suspended in 9 mL of the corresponding broth (TSB, TSB
with 5.0% inulin, TSB with 100 mM glycerol, and TSB with 100 mM glycerol and 5.0%
inulin). They were then incubated again for 2 hours at 37°C with shaking. Subsequently,
each sample was centrifuged at 8000 rcf for 10 minutes. From every tube, 4.5 mL of the
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supernatant was placed into another tube that had 4.5 mL of TSB to render a 1:1 ratio of
supernatant to TSB. Additional controls included 9mL of broth that had not been
cultured with L. reuteri (TSB, TSB with 100mM glycerol, and TSB with 5.0% inulin). All
samples were inoculated with 180 μL from the S. Typhimurium working solution which
consisted of S. Typhimurium culture with an OD596 of 0.1. Initial experiments were then
incubated in a 37°C shaking water bath for 2, 3, 4, 5, 6, and 7 hours. At each time point,
a 1 mL aliquot was taken from each of the samples and measured by spectrophotometry
for their OD596. All conditions were performed in triplicate.
Titration of Reuterin
To titrate reuterin production, the previously described protocols were repeated
except the supernatant was diluted to 1:1, 1:5, 1:10, and 1:15. Further, a 1 mL aliquot
was removed only after 4 hours (during S. Typhimurium growth) for spectrophotometric
analysis.
GOS as primary carbon source
Assays were carried out in a similar manner as stated previously. However,
carbon restricted (glucose free) TSB media was used to make the GOS media. In the
carbon restricted TSB, the following four concentrations of GOS (w/v) were added:
0.25% GOS, 0.25% GOS with glycerol, 2.0% GOS, and 2.0% GOS with glycerol. As
previously noted, glycerol concentration started at 20 mM and then was brought up to
100 mM for each control that had glycerol. The positive control was standard TSB, which
contains 13.9 mM of glucose, supplemented with glycerol. The negative control in this
experiment lacked L. reuteri supernatant, and it was used to assess uninhibited growth
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of S. Typhimurium. A 1:5 ratio of supernatant to TSB was used to incubate the S.
Typhimurium. After 4 hours, the S. Typhimurium cultures were assessed by the
spectrophotometer at 596 nm.

Statistical Analysis
The statistical analysis for all experiments was done with a student’s t test to
determine significance of results. A p value < 0.05 was considered to be statistically
significant.

RESULTS

11

Effect of inulin on reuterin production
S. Typhimurium was first grown in the experimental supplements inulin and
glycerol to determine if in the absence of L. reuteri, any inhibition of growth would be
observed. As shown in Figure 2, inulin and glycerol did not inhibit S. Typhimurium
growth. Furthermore, as others have reported, Figure 2 demonstrates that when L.
reuteri was grown without glycerol, and the supernatant was used to culture S.
Typhimurium, there is an absence of any detectable antimicrobial effect. Each S.
Typhimurium sample was measured for growth with the spectrophotometer at an
Controls had negligible effects on S. Typhimurium growth

Absorbance (OD596)

1.2

TSB

0.8

TSB w/ glycerol
TSB w/ inulin
L.r. w/ TSB
L.r. w/ inulin

0.4

0
2

3

4

5

6

7

8

Time (hours)

Figure 2: Glycerol and inulin alone do not inhibit the growth of S. Typhimurium.S. S.
Typhimurium was cultured with or without glycerol and inulin and assessed for growth over 7
hours of log growth. Supernatants from L. reuterin (L.r.) that were cultured with or without
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inulin were also cultured with S. Typhimurium to assess inhibitory capacity. All samples were
completed in triplicate.

OD596. These results indicate that inulin alone does not inhibit S. Typhimurium growth
(Figure 2). However, as shown in Figure 3, supernatants at a 1:1 dilution from L reuteri
cultured in the presence of glycerol inhibit S. Typhimurium growth for every time point
after hour 2 (p<0.001). And while the addition of glycerol significantly inhibited the
growth of S. Typhimurium, the addition of inulin did not further affect this response at a
1:1 dilution as can be seen in Figure 3.
Glycerol with inulin did not increase inhibition

Absorbance (OD596)

1.2

0.8
TSB
L.r. w/ glyerol
L.r. w/ glyerol+inulin

0.4

0
2

3

4

5

6

7

8

Time (hours)

Figure 3: Glycerol with inulin supplementation did not increase inhibition of S. Typhimurium.
S. Typhimurium growth was significantly inhibited by both supernatants that were extracted
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from L. reuteri cultures incubated with glycerol. However, there was no difference in inhibition
between supernatants with glycerol vs. glycerol with inulin at a 1:1 ratio.

Dilution assay
As a 1:1 dilution of supernatants from L. reuteri cultures resulted in complete
inhibition of S. Typhimurium, we asked if effects of inulin would be observed over
smaller dilutions in order to more precisely understand reuterin production. Dilutions
for glycerol cultured L. reuteri with and without inulin were made at 1:1, 1:5, 1:10, and
1:15. S. Typhimurium was then cultured in these varied supernatant dilutions, and the
optical density of S. Typhimurium was assayed after four hours of incubation. The
steady increase of absorbance indicates that the dilutions were within the sensitive
range of our assay’s measurable limits. There was no significant difference observed
between supernatant from L. reuteri grown with glycerol or glycerol plus inulin for any
of the dilutions (Figure 4). These data further suggest that the addition of inulin does
not increase reuterin production. Moreover, the dose dependent increase of
absorbance indicates that the dilutions were within the sensitive range of our assay’s
measurable limits.
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1
0.9

Absorbance (od596)

0.8
0.7
0.6
0.5

SN w/ gly

0.4

SN w/ gly + inu

0.3

TSB

0.2
0.1
0
1 to 1

1 to 5

1 to 10

1 to 15

Dilutions

Figure 4: Titration of reuterin production is not influenced by inulin supplementation.
Supernatants were prepared from L. reuteri grown with glycerol and glycerol with inulin. Each
were diluted accordingly before use in the assay. All dilutions inhibited S. Typhimurium growth.
There was no significant difference between glycerol and glycerol with inulin at any dilution
(p>0.05).

The data obtained from Figure 4 further suggests to reject the first hypothesis that
suggested the addition of inulin would increase reuterin production.
GOS as a primary carbon source
The supernatant of L. reuteri grown with GOS as the primary carbon source was
used to determine whether L. reuteri can produce reuterin while metabolizing other
carbohydrate sources other than glucose. As expected, the supernatants without any
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glycerol supplementation did not inhibit S. Typhimurium growth significantly (Figure 5).

Reuterin production with GOS as carbon source
1.4

Absorbance (OD596)

1.2
1
0.8
0.6
0.4
0.2
0
Glucose + gly

.25% GOS

.25% GOS +gly

2% GOS

2% GOS + gly

SN (-)

Figure 5: Reuterin production with GOS as primary carbon source is sufficient to inhibit S.
Typhimurium growth. Both concentrations of GOS at 0.25% or 2% allowed for reuterin
production to occur thus the inhibition. Though significant inhibition was observed, there was
also significant difference between the negative control and the GOS with glycerol supernatants.

While not as potent as TSB that contains glucose as a carbon source, the addition of
glycerol to GOS as a primary carbon source, at both concentrations tested, significantly
inhibited the growth of S. Typhimurium (p<0.01). This suggests that L. reuteri can
secrete reuterin while metabolizing carbohydrates other than glucose. Also, the
negative control of the supernatant from glucose with glycerol was significantly lower
than every other sample (p<0.05).
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DISCUSSION
We were able to consistently recreate the study of reuterin’s inhibitory effects
on S. Typhimurium by De Weirdt et al. (De Weirdt et al., 2012). While no inhibitory
ability was observed by the addition of inulin, it cannot be entirely ruled out that the
metabolism of inulin does not promote any inhibitory reuterin production. Even though
it is known that some L. reuteri species can use inulin (Kassim et al., 2014), metabolism
was not confirmed in this study, and it is possible that the L. reuteri did not metabolize
the inulin much, if at all, because it was in the glucose rich carbon environment of the
TSB. Furthermore, other studies have shown that certain strains of L. reuteri do not
metabolize inulin at all (Adebola, Corcoran, & Morgan, 2014; Kneifel, 2000). So while
this research demonstrated for the first time that an addition of inulin does not increase
the production of reuterin with or without glycerol, it did not answer the question of
whether it would have if inulin were the sole carbon source in the media. To better
construct a more thorough assay would require a carbon restricted media, which would
shift L. reuteri to metabolize the inulin. However, the promise of continuing this line of
experimentation may be limited. Two studies looked at the effect that a variety of
prebiotcs had on different probiotics. These studies seem to imply that prebiotic
utilization is strain specific. For example, inulin was not well metabolized by the strains
used in at least two studies(Adebola et al., 2014; Kneifel, 2000). Contrarily, Kassim et al.
showed that some L. reuteri strains did metabolize inulin (Kassim et al., 2014).
Nevertheless, the PTA 6475 strain used in this study has not tested for its ability to
metabolize inulin in any literature reviewed. Therefore, the PTA 6475 strain cannot yet
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be said with great confidence that it does not metabolize inulin when in a carbon
restricted media. This is one area of study yet to be explored.
A new direction to be followed is how other carbohydrate sources effect reuterin
production. One study particularly has already shown that carbohydrate sources can act
synergistically to impact antimicrobial production. (Tzortzis, Baillon, Gibson, & Rastall,
2004). A logical continuation of this would be to extend a study to incorporate different
prebiotics to see if they impact antimicrobial output. This is precisely what was done
with the GOS assay. The carbon restricted media (no glucose) was supplemented with
GOS as the primary carbon source for L. reuteri. A study conducted by Lüthi-Peng,
Dileme, and Puhan demonstrated that reuterin synthesis is optimized at a particular
glycerol to glucose ratio. Following this line of thought, their study would seem to
insinuate that carbohydrate metabolism does indeed impact reuterin output (LüthiPeng, Dileme, & Puhan, 2002). Supported by this study, the GOS assay was completed in
order to better determine the relationship between reuterin synthesis and
carbohydrate metabolism. This research showed for the first time that reuterin can be
metabolized without glucose being the primary carbon source.
Discovering L. reuteri’s ability to continue to synthesize reuterin with GOS as a
primary carbon source brought great insight into this unique form of metabolism (Figure
5). Going forward, there is still much to continue to study. For one, there was a
significant difference in inhibition between glucose and GOS as the carbon source. It is
known that different factors impact the production of different metabolites. (Årsköld et
al., 2007). One study by Liu and Yu revealed that the ratio of glucose to glycerol can be
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optimized for the production of reuterin. (Liu & Yu, 2015). Future studies should
determine whether there is an optimal ratio of GOS to glycerol in the same way that
others have previously found the ideal glucose to glycerol ratio.
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